Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)
China · Delayed Price · Currency is CNY 16.94
+0.46 (2.79%)
At close: Mar 6, 2026
SHA:688488 Market Cap
SHA:688488 has a market cap or net worth of 7.13 billion as of March 6, 2026. Its market cap has increased by 124.67% in one year.
Market Cap
7.13B
Enterprise Value
7.30B
Revenue
720.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.94
Market Cap Chart
Since July 20, 2020, SHA:688488's market cap has decreased from 12.99B to 7.13B, a decrease of -45.11%. That is a compound annual growth rate of -10.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 7.13B | 3.74% |
| Dec 31, 2025 | 6.87B | 107.76% |
| Dec 31, 2024 | 3.31B | -37.17% |
| Dec 29, 2023 | 5.26B | 18.91% |
| Dec 30, 2022 | 4.43B | -32.31% |
| Dec 31, 2021 | 6.54B | -37.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanjing Vazyme Biotech | 8.06B |
| Anhui Huaheng Biotechnology | 7.99B |
| Suzhou Fengbei Biotech Stock | 7.92B |
| Zhejiang Ausun Pharmaceutical | 7.83B |
| Acrobiosystems | 7.53B |
| Wuhan Keqian Biology Co.,Ltd | 7.43B |
| Shenzhen Weiguang Biological Products | 6.66B |
| Lifecome Biochemistry | 6.55B |